Aevi Genomic Medicine Competitors and Similar CompaniesClear all
Aevi Genomic Medicine's competitors and similar companies include Lexicon Pharmaceuticals and CRISPR Therapeutics.
 Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. | ||
Founding Date | Founding Date 2000 | Founding Date 1995 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Wayne, US HQ San Francisco, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US |
Employees | Employees 1418% decrease | Employees 20216% increase | Employees 393 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 737.4 m | Valuation ($) 4.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income ($30.8m) (FY, 2018) | Net income ($50.3m) (FY, 2025) | Net income ($581.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 7m | Total funding raised $ 244.7m | Total funding raised $ 127m |
For sources of this data, please see the company profile
View Company Profiles
Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View companyCRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View company